The article addresses this at the end: Kurzweil, et al are banking on dramatic changes in medicine on the level of the introduction of antibiotics. Right now we're possibly at the farthest end of the antibiotics-and-surgery technology suite. Much longer life expectancies or actuarial escape velocity will need to come from a disruptive medical technology.